parapoxvirus ovis
Recently Published Documents


TOTAL DOCUMENTS

31
(FIVE YEARS 0)

H-INDEX

12
(FIVE YEARS 0)

2019 ◽  
Vol 50 (2) ◽  
pp. 565-569 ◽  
Author(s):  
Ricardo Almeida da Costa ◽  
Juliana Felipetto Cargnelutti ◽  
Carlos Omar Schild ◽  
Eduardo Furtado Flores ◽  
Franklin Riet-Correa ◽  
...  

Vaccines ◽  
2017 ◽  
Vol 5 (3) ◽  
pp. 28 ◽  
Author(s):  
Erika Hue ◽  
Eric Richard ◽  
Christine Fortier ◽  
Guillaume Fortier ◽  
Romain Paillot ◽  
...  
Keyword(s):  

2017 ◽  
Vol 08 (05) ◽  
Author(s):  
H Von Buttlar ◽  
M Protschka ◽  
M Muhsen ◽  
G Köhler ◽  
H Lang ◽  
...  

2016 ◽  
Vol 88 (3) ◽  
pp. 1451-1457
Author(s):  
TATIANA R. PAVAN ◽  
CRISTIAN O. NIED ◽  
MIRELA NORO ◽  
DENIZ ANZILIERO ◽  
RAFAEL FRANDOLOSO ◽  
...  

2016 ◽  
Vol 39 ◽  
pp. S69
Author(s):  
E. Hue ◽  
E. Richard ◽  
C. Fortier ◽  
G. Fortier ◽  
R. Paillot ◽  
...  
Keyword(s):  

2016 ◽  
Vol 78 (1) ◽  
pp. 129-131 ◽  
Author(s):  
Oguzhan AVCI ◽  
Oya BULUT ◽  
Irmak DIK

2014 ◽  
Vol 59 (No. 12) ◽  
pp. 631-636
Author(s):  
CP Ulgen S Yaramis ◽  
E. Rayaman ◽  
U. Soyogul Gurer ◽  
ME Or ◽  
AO Sehirli

Immunomodulatory products have been used for years in veterinary medicine. Inactivated Parapoxvirus ovis (iPPVO) is currently used in equine medicine as an immunomodulator to improve the immune system and as a prophylactic treatment to prevent or treat infectious diseases. This study was designed to determine the effects of iPPVO on polymorphonuclear leukocyte (PMNL) function (phagocytosis and intracellular killing activity) and the myeloperoxidase (MPO) activity of PMNLs in horses. Twenty-four healthy English thoroughbred horses with an average age of 11 years were included in the study. Venous blood samples (10 ml) were taken before (agent-free controls) and after the administration of iPPVO (2 ml i.m. injection on Days 1, 3, and 5). PMNLs (1&nbsp;&times;&nbsp;10<sup>7</sup> cells/ml) were isolated from venous blood containing EDTA (0.1 g/ml) with Ficoll-Hypaque gradient centrifugation. Cellular phagocytosis and intracellular killing activities were assayed using a modification of Alexander&rsquo;s method before and after treatment with iPPVO. MPO activity was also measured. The administration of iPPVO significantly increased the phagocytic, intracellular killing, and MPO activities of equine PMNLs (P = 0.0058, P&nbsp;= 0.0050, and P = 0.0070, respectively). This study demonstrates a strong correlation between MPO activity and PMNL function. The administration of iPPVO to horses has a supportive effect on their cellular immunity and an immunomodulatory effect against equine viral infections.


PLoS ONE ◽  
2014 ◽  
Vol 9 (8) ◽  
pp. e106188 ◽  
Author(s):  
Heiner von Buttlar ◽  
Sabine Siegemund ◽  
Mathias Büttner ◽  
Gottfried Alber

2014 ◽  
Vol 289 (1-2) ◽  
pp. 36-41 ◽  
Author(s):  
D. Anziliero ◽  
L.C. Kreutz ◽  
E.F. Flores ◽  
R. Weiblen

Sign in / Sign up

Export Citation Format

Share Document